These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. Crosbie RH; Barresi R; Campbell KP FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321 [TBL] [Abstract][Full Text] [Related]
4. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy]. Wang S; Shen D Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148 [TBL] [Abstract][Full Text] [Related]
5. Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice. Li D; Yue Y; Lai Y; Hakim CH; Duan D J Pathol; 2011 Jan; 223(1):88-98. PubMed ID: 21125668 [TBL] [Abstract][Full Text] [Related]
7. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030 [TBL] [Abstract][Full Text] [Related]
8. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463 [TBL] [Abstract][Full Text] [Related]
9. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders. Finanger Hedderick EL; Simmers JL; Soleimani A; Andres-Mateos E; Marx R; Files DC; King L; Crawford TO; Corse AM; Cohn RD Neurology; 2011 Mar; 76(11):960-7. PubMed ID: 21403107 [TBL] [Abstract][Full Text] [Related]
10. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS. Meinen S; Lin S; Rüegg MA; Punga AR PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study. Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664 [TBL] [Abstract][Full Text] [Related]
12. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy. Guo Y; Petrof BJ; Hussain SN Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948 [TBL] [Abstract][Full Text] [Related]
14. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881 [TBL] [Abstract][Full Text] [Related]
15. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies. Becker N; Moore SA; Jones KA Acta Neuropathol Commun; 2022 Feb; 10(1):17. PubMed ID: 35135626 [TBL] [Abstract][Full Text] [Related]